CAGRISEMA 10 mg (COA IN IMAGES)
$120.00
A dual-agonist research compound targeting GLP-1 and amylin receptor pathways, investigated for synergistic metabolic regulation.
Cagrisema is a research compound combining GLP-1 receptor agonism with amylin receptor activity. This dual-pathway approach is studied for its effects on incretin signaling and appetite-regulating neural circuits simultaneously. Preclinical models have examined its influence on gastric motility, glucose-dependent insulin secretion, and central satiety signaling. For research and laboratory use only. Not for human consumption.
| Weight | .1 lbs |
|---|---|
| Dimensions | 3 × 2 × 2 in |
Reviews
Clear filtersThere are no reviews yet.